Carl Danzig

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Beacon Therapeutics
    Topic:
    AMD
    Date added:
    04/06/2026
    Date updated:
    04/06/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Stealth
    Topic:
    AMD
    Date added:
    04/06/2026
    Date updated:
    04/06/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Unity
    Topic:
    AMD, DME
    Date added:
    04/06/2026
    Date updated:
    04/06/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Unity
    Topic:
    AMD, DME
    Date added:
    04/06/2026
    Date updated:
    04/06/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Samsung Bioepsis
    Topic:
    AMD
    Date added:
    04/06/2026
    Date updated:
    04/06/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    OcuCool
    Topic:
    injections
    Date added:
    04/06/2026
    Date updated:
    04/06/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Sanofi
    Topic:
    AMD
    Date added:
    04/06/2026
    Date updated:
    04/06/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Outlook Therapeutics
    Topic:
    AMD, DME
    Date added:
    04/06/2026
    Date updated:
    04/06/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Opthea
    Topic:
    AMD
    Date added:
    04/06/2026
    Date updated:
    04/06/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Apellis
    Date added:
    04/06/2026
    Date updated:
    04/06/2026

Pages

Return to Masters in Ophthalmology 2026